Latest Medtech News
RF Medical, a South Korean developer of minimally invasive treatment systems, has obtained CE marking under the EU Medical Device Regulation (MDR) for its Mi-BLATOR microwave ablation system. The certification covers both the generator and the antennas and allows the company to introduce the system to the European market.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
The antenna uses a proprietary feedline design to create a spherical ablation zone. The generator has a multi-step mode that lets users set power and duration for each step within a single ablation cycle, which the company says supports treatment planning.
For RF Medical, the certification extends its European offering beyond radiofrequency ablation. The company says microwave technology complements its established RF portfolio and creates openings to strengthen distribution partnerships and reach new customers across Europe. It gives healthcare professionals there an additional thermal ablation option.
The announcement follows the September 2026 CE marking under the EU MDR of THYBLATE-V2, an adjustable-tip thyroid RF ablation electrode that already holds Korean authorization and FDA 510(k) clearance.
For the broader MedTech space, the news is another example of manufacturers widening their ablation lines through MDR certification, with microwave joining radiofrequency in a single company’s European portfolio.
